Sunday, September 23, 2018
Close  

Precision cancer therapy works in 3/4 of patients, says study

/ 06:29 PM February 22, 2018
Read Next
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Cancer, larotrectinib, Precision cancer therapy, tropomyosin receptor kinase fusions
For feedback, complaints, or inquiries, contact us.
newsinfo

Children’s remains found in Mexican mass graves

September 24, 2018 07:18 AM

business

No oil production hike — OPEC

September 24, 2018 07:09 AM



© Copyright 1997-2018 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.